The founder of Insys Therapeutics and a group of colleagues are accused of providing kickbacks to doctors to widely prescribe a fentanyl-based spray called Subsys, intended only for cancer patients with intense pain.
The founder of Insys Therapeutics and a group of colleagues are accused of providing kickbacks to doctors to widely prescribe a fentanyl-based spray called Subsys, intended only for cancer patients with intense pain.